HDAC9 and Alzheimer disease: It was recently reported that sirtuin 6 (SIRT6), a protein presenting with HDAC-like senotherapeutic properties, inhibits NF-κB and EC senescence, suggesting AD therapeutic benefits (Lappas, 2012; Zhao et al., 2016).